View in EDS HTML Full Text PDF Full Text

PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.

Saved in:
Bibliographic Details
Title: PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.
Authors: Yang X; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Obstetrics and Gynecology, Second Xiangya Hospital, Central South University, Changsha, China., Liu Z; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China., Tang W; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Obstetrics and Gynecology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, China., Pratap UP; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Collier AB; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Altwegg KA; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA., Gopalam R; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Li X; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Yuan Y; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, TX, USA., Zhou D; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, TX, USA., Lai Z; Department of Molecular Medicine, Department of Population Sciences, and Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Chen Y; Department of Molecular Medicine, Department of Population Sciences, and Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Sareddy GR; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA., Valente PT; Department of Pathology, University of Texas Health San Antonio, TX, USA., Kost ER; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA., Viswanadhapalli S; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA., Vadlamudi RK; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA.; Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, TX, USA.
Source: Molecular oncology [Mol Oncol] 2024 Sep; Vol. 18 (9), pp. 2136-2156. Date of Electronic Publication: 2023 Nov 01.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37853941
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yang+X%22">Yang X</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Obstetrics and Gynecology, Second Xiangya Hospital, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Tang+W%22">Tang W</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Department of Obstetrics and Gynecology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, China.<br /><searchLink fieldCode="AU" term="%22Pratap+UP%22">Pratap UP</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Collier+AB%22">Collier AB</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Altwegg+KA%22">Altwegg KA</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gopalam+R%22">Gopalam R</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+D%22">Zhou D</searchLink>; Department of Biochemistry & Structural Biology, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lai+Z%22">Lai Z</searchLink>; Department of Molecular Medicine, Department of Population Sciences, and Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Molecular Medicine, Department of Population Sciences, and Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sareddy+GR%22">Sareddy GR</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Valente+PT%22">Valente PT</searchLink>; Department of Pathology, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kost+ER%22">Kost ER</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Viswanadhapalli+S%22">Viswanadhapalli S</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Vadlamudi+RK%22">Vadlamudi RK</searchLink>; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, TX, USA.; Mays Cancer Center, University of Texas Health San Antonio, TX, USA.; Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2024 Sep; Vol. 18 (9), pp. 2136-2156. <i>Date of Electronic Publication: </i>2023 Nov 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37853941
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.13539
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2136
    Titles:
      – TitleFull: PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang X
      – PersonEntity:
          Name:
            NameFull: Liu Z
      – PersonEntity:
          Name:
            NameFull: Tang W
      – PersonEntity:
          Name:
            NameFull: Pratap UP
      – PersonEntity:
          Name:
            NameFull: Collier AB
      – PersonEntity:
          Name:
            NameFull: Altwegg KA
      – PersonEntity:
          Name:
            NameFull: Gopalam R
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Yuan Y
      – PersonEntity:
          Name:
            NameFull: Zhou D
      – PersonEntity:
          Name:
            NameFull: Lai Z
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Sareddy GR
      – PersonEntity:
          Name:
            NameFull: Valente PT
      – PersonEntity:
          Name:
            NameFull: Kost ER
      – PersonEntity:
          Name:
            NameFull: Viswanadhapalli S
      – PersonEntity:
          Name:
            NameFull: Vadlamudi RK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1